Despite Clinician Hesitancy, Data Support Use of Rivaroxaban in Patients with PAD, CKD
April 3rd 2022Mark Svet, MD, is the lead study author on a sub-analysis of the VOYAGER PAD study evaluating data on the use of rivaroxaban in patients with peripheral artery disease (PAD) and chronic kidney disease (CKD).
Watch
Data Show Rivaroxaban Lowers Severe Vascular Event Risk in Patients With PAD
April 3rd 2022Results of the phase 3 VOYAGER PAD clinical trial show rivaroxaban (Xarelto; Janssen Pharmaceutical Companies) plus aspirin lowers severe vascular events in patients with peripheral arterial disease after lower-extremity revascularization.
Read More
Pharmacists Can Help Manage Disparities in Health Care Access
April 2nd 2022Pharmacy Times spoke with Orly Vardeny, PharmD, MS, a core investigator at the Center for Care Delivery and Outcomes Research in the US Department of Veterans Affairs, about pharmacists’ roles in managing pharmacotherapy disparities.
Watch
The Complicated Role of Oncology Pharmacist/Caregiver in Managing Patient Care, Treatment
April 1st 2022Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses some of the barriers that patients with cancer may encounter following their diagnosis.
Watch
Pharmacy Students Tackle Clinical Questions in Round 2 of Pharmacy Times® Pharmacy Face-Off Gameshow
April 1st 2022In part 2 of the Pharmacy Times® Pharmacy Face-Off Gameshow™, pharmacy students from the University of the Sciences Philadelphia College of Pharmacy and the Rutgers University Ernest Mario School of Pharmacy entered a lightning round with clinical questions.
Watch